Regulation of human mast cell tryptase. Effects of enzyme concentration, ionic strength and the structure and negative charge density of polysaccharides
- 15 December 1987
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 248 (3) , 821-827
- https://doi.org/10.1042/bj2480821
Abstract
Tryptase was previously shown to undergo rapid inactivation under physiological conditions unless stabilized by the presence of heparin. The current study shows that increasing the concentration of free tryptase enhances the preservation of enzymic activity, consistent with dissociation of the tetramer, rather than autodegradation, as the mechanism of inactivation. Heparin glycosaminoglycan fragments of Mr greater than 5700 are necessary for complete stabilization of tryptase activity. This stabilizing effect depends upon negative charge density rather than carbohydrate composition. Thus, keratan sulphate or hyaluronic acid were no better than physiological buffer alone; chondroitin monosulphates and heparan sulphate each prolonged the t1/2 about 20-fold over buffer alone; chondroitin sulphate E prolonged the t1/2 69-fold; and dextran sulphate and heparin provided complete stabilization of tryptase activity for 120 min. Poly-D-glutamic acid prolonged the t1/2 55-fold. In each case the loss of tryptase activity followed apparent first-order kinetics. Increasing the NaCl concentration from 0.01 M to 1.0 M increased the stability of free tryptase. In contrast, increasing the NaCl concentration in the presence of stabilizing polysaccharides decreased the stability of tryptase until dissociation of tryptase from each polysaccharide presumably occurred; thereafter tryptase stability increased as did that of free tryptase. The effect of salt concentration on heparin-stabilized tryptase activity (as opposed to stability) was also evaluated. The mast cell proteoglycans heparin and chondroitin sulphate E, by virtue of containing the naturally occurring glycosaminoglycans of highest negative charge density, may play a major role in the regulation of mast cell tryptase activity in vivo.This publication has 35 references indexed in Scilit:
- Deficiency of the tryptase-positive, chymase-negative mast cell type in gastrointestinal mucosa of patients with defective T lymphocyte function.The Journal of Immunology, 1987
- Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells.The Journal of Immunology, 1987
- Biochemical and functional characterization of proteoglycans isolated from basophils of patients with chronic myelogenous leukemia.The Journal of Immunology, 1984
- Ultrastructural, biochemical, and functional characteristics of histamine-containing cells cloned from mouse bone marrow: tentative identification as mucosal mast cells.The Journal of Immunology, 1983
- Evidence for control of mast cell granule protease in situ by low pH*1Experimental Cell Research, 1983
- Culture from mouse bone marrow of a subclass of mast cells possessing a distinct chondroitin sulfate proteoglycan with glycosaminoglycans rich in N-acetylgalactosamine-4,6-disulfate.Journal of Biological Chemistry, 1982
- Acid hydrolases and tryptase from secretory granules of dispersed human lung mast cells.The Journal of Immunology, 1981
- Partial purification and characterization of a novel neutral proteinase from human uterine cervixBiochemical Journal, 1980
- Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b.The Journal of Experimental Medicine, 1979
- Native heparin from rat peritoneal mast cells.Journal of Biological Chemistry, 1977